Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$28.12
Price-2.50%
-$0.72
1Y
Price
Market Cap
$1.697b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-53.9%
EBITDA Margin-60.4%
Net Profit Margin-26.6%
Free Cash Flow MarginRevenue
$362.273m
+13.2%
1y CAGR+29.2%
3y CAGR+33.6%
5y CAGREarnings
-$85.187m
+6.1%
1y CAGR-10.3%
3y CAGR-9.9%
5y CAGREPS
-$1.46
+6.7%
1y CAGR-3.6%
3y CAGR+0.3%
5y CAGRBook Value
$478.198m
$643.605m
Assets$165.407m
Liabilities$78.150m
DebtDebt to Assets
12.1%
-0.5x
Debt to EBITDAFree Cash Flow
-$68.713m
+43.9%
1y CAGR+2.1%
3y CAGR+3.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company